			The shift from volume- to performance-based payment is propelling life sciences companies to seek concrete data and medical evidence – both to understand patient care and to demonstrate the effectiveness, safety and value of drug therapies. To help life sciences clients better manage, analyze and share data, business analytics company 

			The new service features de-identified integrated claims and clinical data about everyday patients receiving health care, including prescriptions and labs – data from the real world, not just trials. For the new platform, Optum, a leading information and technology-enabled health services business and part of United HealthCare, is the first collaborator and will contribute health care expertise, analytics and vast stores of clinical data to the SAS

News

The shift from volume- to performance-based payment is propelling life sciences companies to seek concrete data and medical evidence – both to understand patient care and to demonstrate the effectiveness, safety and value of drug therapies.